ArticleFrontiers in pharmacology2026
Factors associated with clinically diagnosed long QT syndrome in Korean adults: a nationwide case-control study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Long QT syndrome (LQTS) is a major substrate for malignant ventricular arrhythmias, yet population-level evidence on its clinical, pharmacological and metabolic correlates in Asian adults remains limited. Methods: Using Korean National Health Insurance Service claims linked to national health screening data (2012-2022), we conducted a 1:1 age- and sex-matched case-control study to characterize factors associated with LQTS in a nationwide adult population. Cases were identified by LQTS-related diagnostic codes with concurrent electrocardiographic procedure claims, and controls were individuals without any arrhythmia diagnosis. Adjusted odds ratios (aORs) with 95% confidence intervals were estimated by multivariable conditional logistic regression for comorbidities, QT-prolonging drug exposure, and metabolic and laboratory factors, with prespecified subgroup analyses by sex and age. Results: The study included 335,693 cases and 335,693 matched controls (mean age 54.6 years; 48.6% male). Cardiovascular comorbidities, including chronic heart failure and peripheral arterial disease, were among the factors most strongly associated with LQTS. The strength of association increased progressively with the number of concurrently used QT-prolonging drugs, with aORs of 6.70, 11.63 and 15.08 for one, two, and three or more drugs, respectively. Hyperkalaemia, calcium imbalance, central obesity, elevated blood pressure, dyslipidaemia and impaired renal function were also independently associated with LQTS. Associations with hyperkalaemia and thyroid dysfunction were numerically stronger in women, and the drug-related gradient was steepest in older adults. Discussion: These nationwide findings characterize the comorbidity, electrolyte and cumulative drug-exposure factors associated with clinically diagnosed LQTS in Korean adults, and may complement Western-derived tools such as CredibleMeds to inform population-specific pharmacovigilance of QT-prolonging drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.